The production and selection of infectious vaccinia virus recombinants expressing foreign genes was facilitated by the construction of plasmid vectors. These vectors contain all or part of the vaccinia virus thymidine kinase (TK) 
Recombinant DNA technology has made it possible to insert and express heterologous genes in a variety of different viruses (22) . Thus far, simian virus 40 (6, 8, 9, 17) , bovine papillomavirus (26) , adenovirus (30, 32) , and members of the retrovirus family (27, 38) have been used most extensively as expression vectors. Although the relatively small size of these viruses facilitates genetic engineering, this property also restricts the amount of DNA that can be inserted into the virus particle. In addition, virus vectors usually have a limited host range and are defective, requiring either helper virus or special cell lines for replication. The large size and extensive host range of vaccinia virus and related poxviruses suggest that they could be useful as vectors. Indeed, initial experiments indicate that vaccinia virus vectors retain infectivity (11, 21) , accommodate at least 25,000 base pairs (bp) of exogenous DNA (29) , and synthesize foreign gene products that are properly processed and glycosylated (28, 28a) . Furthermore, experimental animals that were vaccinated intradermally with recombinants containing the hepatitis B virus surface antigen gene (28) and the influenza virus hemagglutinin gene (Smith et al., in press) or infected intravenously with the latter (20) produced high antibody levels. Protection of vaccinated animals against respiratory influenza infection (Smith et al., in press) demonstrated the potential use of such vectors as live vaccines.
The strategy used previously in our laboratory to insert and express foreign DNA in vaccinia virus (11, 16) took into account the large size (187,000 bp) of the genome (5), the noninfectious nature of isolated DNA (24) , evidence that vaccinia virus genes contain unique transcriptional regulatory signals recognized by the viral RNA polymerase (21a, 33, 34, 40) , marker rescue techniques (18, 24, 39) , and the * Corresponding author. ability of homologous sequences in plasmid and virus DNA to recombine within infected cells (39) . We constructed a plasmid containing a chimeric gene, consisting of a vaccinia virus promoter fused to a foreign protein-coding sequence, flanked by DNA from a nonessential region of the vaccinia virus genome. The plasmid was used to transfect cells already infected with vaccinia virus so that homologous recombination could occur between the sequences flanking the chimeric gene and the same sequences within the vaccinia virus genome. Recombinants were selected either by their expression of the inserted herpesvirus thymidine kinase (TK) gene or by inactivation of the vaccinia virus TK. The latter was achieved by insertion of the foreign DNA into the coding sequence of the previously mapped (1, 10, 39) and sequenced (40) vaccinia virus TK gene. A related approach of insertional inactivation of the TK gene has been used to produce and select herpesvirus recombinants (15) .
In this communication, we (2) . DNA fragments were isolated from agarose gels by electrophoresis onto DEAE paper (41) . Recombinant phages were prepared from M13mp8 or M13mp9 (14) and used for sequencing by the dideoxy method of Sanger et al. (25) . Routine procedures were similar to those described in detail by Maniatis et al. (12) .
Bal31 deletion. A 25-Rg sample of a plasmid derived from pUC9 by insertion of the vaccinia virus HindlIl J fragment was cleaved with Clal (Boehringer Mannheim) in 20 mM Tris-hydrochloride (pH 8.1)-6 mM MgCl2-50 mM NaCl. After complete digestion, the buffer composition was altered to 100 mM NaCl-12 mM CaCI2-1 mM disodium EDTA and incubated at 30°C for 10 min. Two units of exonuclease Bal31 was added, and 6-,ug samples were removed at 1, 2, 5 and 10 min after the addition of the nuclease. A 1-pg portion of each sample was cleaved with HindlIl, and the fragments were separated on a 1% agarose gel. The 10-min sample reduced the average size of the smallest fragment to approximately 500 bp, and this sample was chosen for further manipulation.
Marker rescue. Marker rescue was performed essentially as described previously (39 (35) with HincIl and RsaI. This bluntended fragment was inserted into the unique HincIl site of pUC9. The resulting plasmid, which contains the RNA start site near the BamHI and SmaI sites of pUC9, was designated pGS15 (Fig. 3) . The HindIll site of pGS15 was changed to an EcoRI site by cleaving pGS15 with Hindlll, filling in the staggered ends with DNA polymerase, and ligating a synthetic EcoRI linker. By cleavage of the resultant plasmid (pGS19) with EcoRI, a 290-bp EcoRI fragment was isolated that contained the 7.5K gene promoter and RNA start site adjacent to BamHI and SmaI sites (Fig. 3) . This fragment Fig. 4 . Inspection of the sequence confirms that there are no cryptic ATG translation initiation codons between the transcriptional start site and the sites for insertion of foreign DNA. Consequently, the translational start site of the foreign gene should be utilized.
Construction of vaccinia virus recombinants that express CAT. A 770-bp TaqI DNA fragment containing the CATcoding sequence separated from its endogenous RNA start site was isolated from pBR328 and cloned into the AccI site of pUC7. Since pUC7 contains BamHI sites closely flanking the AccI sites (36), the CAT gene could be excised with BamHI and inserted into vectors pMM4, pGS20, and pGS21. Recombinant plasmids containing CAT-coding sequences in correct and incorrect polarities with respect to the 7.5K gene promoter were isolated and used for in vivo recombination experiments.
Cells infected with vaccinia virus were transfected with calcium phosphate-precipitated derivatives of pMM4, pGS20, and pGS21 containing the CAT gene. The cells were subsequently harvested, and TK-virus recombinants were isolated by plaque assay on TK-cells in the presence of BUdR (39) . Selected TK-viruses were then grown in small monolayers of TK-cells in the presence of BUdR, and the virus was screened for the presence of the CAT gene DNA by a dot-blot hybridization procedure (11) . Virus positive for CAT DNA was then plaque purified once more in TK-cells with BUdR selection, and large stocks were prepared under nonselective conditions in HeLa S3 cells. The predicted structures of four recombinants are shown in Fig. 5 . Recombinant vCl contains the CAT gene adjacent to the vaccinia virus TK promoter; vC24 and vC30 contain the CAT gene correctly orientated next to the 7.5K gene promoter, but differ in their polarities with respect to flanking DNA. vC31 contains the 7.5K promoter at the distal end of the CAT gene to provide a control for expression experiments.
To confirm their predicted structures, DNA from the above recombinants as well as wild-type vaccinia virus was digested with Hindlll, BamHI, or EcoRI, and the resulting fragments were separated by electrophoresis in 0.6% agarose gel. Staining of the gel with ethidium bromide and illumination with UV light (Fig. 6 ) indicated that the 5-kilobase (kb) HindlIl J fragment (containing the TK gene) of wild-type DNA was absent from the recombinants. Instead, new Hindlll fragments of 5.8 kb in vCl and 6.1 kb in vC24 and vC30 were detected. In each case, these results are consistent with insertion of the CAT gene into the vaccinia virus TK gene.
To further characterize the recombinants, the gel-separated DNA fragments were blotted onto a nitrocellulose sheet and hybridized to 32P-labeled CAT DNA (Fig. 6) the recombinants hybridized to the probe, indicating that the entire CAT-coding sequence was integrated into the viral genome. Since EcoRI cuts asymmetrically within the CAT gene and at sites on either side of it, the orientation of the gene with respect to the vaccinia virus promoter could be readily determined. In the case of vC24 and vC30, EcoRI digestion generates two fragments of almost identical size (550 bp) that hybridize to the 32P-labeled probe (Fig. 6) , thus confirming the predicted structures in Fig. 5 . The recombinant vCl should have one EcoRI site at the distal end of the CAT gene as well as an internal one. However, the nearest upstream EcoRI site should be within the vaccinia virus HindIII G fragment approximately 8.5 kb away (11) . The two predicted EcoRI fragments of 9.5 kb and 550 bp were detected by autoradiography (Fig. 6) . Similar procedures were used to prove the structure of vC31 (data not shown (Fig. 7A ). The amount of CAT was proportional to the multiplicity of the recombinant virus (Fig. 7B) . At the higher virus multiplicities, however, the cells were quite fragile, and considerable amounts of enzyme were released into the medium upon scraping the monolayer. The time course of CAT synthesis in cells infected with the four recombinants is shown in Fig. 8 . CAT was detected within 2 h after vCl infection and peaked at 6 h, reflecting the "early" character of the TK gene promoter. As expected, the addition of cytosine arabinoside, an inhibitor of DNA replication, had little effect on CAT synthesis. Nearly identical levels of CAT were made in cells infected with vC24 or vC30 (Fig. 8) Several studies have established that the vaccinia virus TK gene is expressed at early times (4, 13) . CAT synthesis was detected within 2 h after infection when that gene was under control of the TK promoter, and the inhibition of DNA replication had little or no effect on expression. The apparent fidelity of gene regulation suggests that vaccinia virus recombinants will be useful for analyzing the effects of mutations produced in vitro. The 7.5K gene also is expressed early after infection (35) ; however, its regulation has not been studied in detail. Although CAT synthesis under control of the 7.5K gene promoter was detected within 2 h after infection, significantly reduced levels were made at late times in the presence of an inhibitor of DNA replication. This result suggests differences in regulation of the two promoter regions used in this study.
Control experiments in this study and a previous one of ours (28) indicated that detectable levels of gene expression occurred even when vaccinia virus transcriptional regulatory sequences were not placed adjacent to a foreign proteincoding segment. These low levels of expression might result from the fortuitous presence of a vaccinia virus promoter far upstream or from inefficient utilization of other DNA sequences as promoters and could lead to the formation of fusion proteins. Phenomena of these type could be the basis for the expression of foreign genes obtained by other investigators, especially where long segments of either herpesvirus At the indicated times after infection, 5-ml samples (2.5 x 106 cells) were removed and assayed for CAT at appropriate dilutions. CAT activity is expressed as nanomoles of chloramphenicol acetylated per 2.5 x 106 cells. The scales used in the left and right panels differ by a factor of 25. To ensure that cytosine arabinoside inhibited virus replication, plaque assays were performed. In each case, the 24-h virus titers were considerably lower than the virus input. DNA (21) or plasmid DNA (20) were situated between the coding sequence and any possible vaccinia virus promoter.
If infectivity of the recombinant virus is to be maintained, foreign DNA must be inserted into a nonessential region of the vaccinia virus genome. The TK gene was chosen as an insertion site primarily because interruption of its function provides a method of selection. However, we have also inserted foreign DNA into another nonessential region located near the left end of the vaccinia virus genome (11) . In that case, selection was based on insertion and expression of the herpesvirus TK gene, which was recombined into TKvaccinia virus. Still another nonessential region suitable for cloning was used by others (21) .
In this communication, the CAT,gene was used as a model system because of the sensitive and quantitative nature of the enzyme assay. However, a variety of other genes also have been introduced into vaccinia virus using the insertion vectors described here. These include the hepatitis B virus surface antigen (28) , the influenza virus hemagglutinin (28a) , and the herpes simplex virus type 1 glycoprotein D (M. Mackett and B. Moss, unpublished data). In each case, the polypeptide synthesized was similar or identical to the natural product and reacted with antibodies to the latter.
